68Ga-DOTA-JR11

unknown · Memorial Sloan Kettering Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 68Ga-DOTA-JR11, covering 2022-02-01 to 2022-02-01. Get the full timeline:

Most recent: Clinical Trial Update: Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors [NA]

See pricing